Keywords
How to Cite
Abstract
Purpose: The present prospective cross sectional study was aimed to access the prevalence and trend of Multi-Drug Resistant Tuberculosis (MDR-TB) in different age groups and gender, in the city of Lahore, Pakistan. Tuberculosis is a disease of poverty affecting mostly young adults in their most productive years; however, all age groups are at risk.
Method: The study population consisted of patients under DOT program with MDR-TB among males and females and in different categories of age groups. The data was collected from 100 MDR-TB patients from 7800 TB patients that were admitted in duration of 6 months and analyzed to evaluate the drug resistance associated with patient’s noncompliance. Moreover, drugs resistance ratio was also calculated from the data.
Results: TB is a specific infectious disease, caused by M. tuberculosis strains, which is becoming resistant to anti-tuberculosis agents especially to Isoniazid and Rifampicin that are two key drugs of TB treatment and are termed as MDR-TB. The disease was seen in 66% males and 34% in female. The highest drug resistance ratio was in found in adults (age group).
References
Organization WHO. Global tuberculosis report 2013: World Health Organization; 2013.
McPhee SJ, Papadakis MA, Rabow MW, Education M-H. Current medical diagnosis & treatment 2010: McGraw-Hill Medical; 2010.
Organization WHO. Global tuberculosis control: WHO report 2010: World Health Organization; 2010.
Wood AJ, Iseman MD. Treatment of multidrug-resistant tuberculosis. New England Journal of Medicine 1993; 329(11): 784-91. https://doi.org/10.1056/NEJM199309093291108
Dye C, Bassili A, Bierrenbach A, Broekmans J, Chadha V, Glaziou P, et al. Measuring tuberculosis burden, trends, and the impact of control programmes. The Lancet infectious diseases 2008; 8(4): 233-43. https://doi.org/10.1016/S1473-3099(07)70291-8
Tanveer M, Hasan Z, Siddiqui AR, Ali A, Kanji A, Ghebremicheal S, et al. Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. BMC infectious diseases 2008; 8(1): 171. https://doi.org/10.1186/1471-2334-8-171
Organization WHO. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009: World Health Organization; 2009.
Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One 2009; 4(9): e6914.
Shehzadi R, Irfan M, Zohra T, Khan JA, Hussain SF. Knowledge regarding management of tuberculosis among general practitioners in northern areas of Pakistan. Journal-Pakistan Medical Association 2005; 55(4): 174.
Awofeso N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bulletin of the World health Organization 2008; 86(3): B-D.
Lomtadze N, Aspindzelashvili R, Janjgava M, Mirtskhulava V, Wright A, Blumberg HM, et al. Prevalence and risk factors for multidrug-resistant Tuberculosis in Republic of Georgia: a population based study. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 2009; 13(1): 68.
Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS medicine 2011; 8(7): e1001067. https://doi.org/10.1371/journal.pmed.1001067
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2018 Journal of Basic & Applied Sciences